ALLISON CORZATT: Open Payments
NPI 1992309777 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 55 payments from 20 companies in 2025. Trend: 2023 $1,545 · 2024 $809 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $211 |
| ABBVIE INC. | 8 | $181 |
| AstraZeneca Pharmaceuticals LP | 4 | $157 |
| Novo Nordisk Inc | 4 | $92 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| GlaxoSmithKline, LLC. | 2 | $63 |
| Amgen Inc. | 2 | $59 |
| SANOFI-AVENTIS U.S. LLC | 2 | $46 |
| Merck Sharp & Dohme LLC | 3 | $45 |
| ABIOMED | 1 | $34 |
Products named: NURTEC ODT, NEXIUM, GEMTESA, QULIPTA, KRYSTEXXA, PREVNAR 20, VRAYLAR, UBRELVY.
Industry payments across CO — which companies pay providers there.
